March 30, 2015 | Israeli pharmaceutical giant Teva Pharmaceutical Industries has agreed to acquire Auspex Pharmaceuticals for $3.5 billion. The acquisition will strengthen Teva’s portfolio of treatments for the central nervous system. Teva was originally founded in 1901 as Salomon, Levin, and Elstein.
Related posts
Israeli Cybersecurity Startup To Provide Training For IDF
October 10, 2024
Johnson & Johnson Completes Purchase Of Israeli Startup V-Wave
October 10, 2024
Weizmann Researchers Create Biodegradable Composite Plastic
October 09, 2024
IIA Funds Further Israeli R&D Into Crustacean Gene Modification
October 09, 2024
Facebook comments